H. B. Fuller (FUL) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended May 2026, H. B. Fuller (FUL) reported revenue of $950.27 million, up 5.8% over the same period last year. EPS came in at $1.41, compared to $1.18 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $926.93 million, representing a surprise of +2.52%. The company delivered an EPS surprise of +3.05%, with the consensus EPS estimate being $1.37.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how H. B. Fuller performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Net Revenue- Hygiene, Health and Consumable Adhesives: $421.86 million compared to the $399.27 million average estimate based on two analysts. The reported number represents a change of +6.1% year over year.Net Revenue- Building Adhesive Solutions: $245.17 million versus $233.26 million estimated by two analysts on average.Net Revenue- Engineering Adhesives: $283.24 million compared to the $294.54 million average estimate based on two analysts. The reported number represents a change of +2.5% year over year.Adjusted EBITDA- Engineering Adhesives: $63.54 million versus $70.65 million estimated by two analysts on average.Adjusted EBITDA- Building Adhesive Solutions: $41.41 million compared to the $40.13 million average estimate based on two analysts.Adjusted EBITDA- Hygiene, Health and Consumable Adhesives: $75.56 million versus $65.42 million estimated by two analysts on average.View all Key Company Metrics for H. B. Fuller here>>>Shares of H. B. Fuller have returned +4.2% over the past month versus the Zacks S&P 500 composite's -1.3% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.7% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>This article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks